BLS Pharmaceuticals Limited (ASX: BLS)
Health Care · Life Sciences Tools & Services · AU
AU$0.95
+0.53% today · +75.0% 1Y
BLS Pharmaceuticals Limited (ASX: BLS) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $155.78M and employs 16 people.
Over the last twelve months the share price has gained 75.0%, trading between 0.33 and 1.10.
Tweenvest scores BLS Pharmaceuticals Limited across four factors: quality 60/100, value 49/100, growth 100/100. Its strongest factor is growth.
BLS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $155.78M
- Revenue (TTM)
- $31.99M
- P/E
- 23.81
- EPS
- 0.04
- Dividend yield
- —
- Beta (5Y)
- 0.62
- 52-week high
- AU$1.10
- 52-week low
- AU$0.33
- Avg volume (3M)
- —
- Shares outstanding
- 229.98M
- Employees
- 16
- Next earnings
- —
About BLS Pharmaceuticals Limited
BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.
- ISIN
- AU0000477796
- Founded
- 1998
- Listed since
- Dec 12, 2000
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.47B | $628.74 | -0.08% |
| Danaher CorporationNYSE: DHR | $151.22B | $215.11 | -1.71% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $69.06B | CN¥155.84 | -4.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.21B | CHF592.00 | +0.71% |
| Agilent Technologies, Inc.NYSE: A | $43.33B | $153.43 | -3.50% |
| IQVIA Holdings Inc.NYSE: IQV | $42.84B | $260.24 | +0.16% |
| Waters CorporationNYSE: WAT | $40.36B | $410.75 | +0.01% |
Figures last refreshed Aug 18, 2026.